Isoxazolone based inhibitors of p38 MAP kinases

被引：36

作者：

Laufer, Stefan A. ^{[1
]}

Margutti, Simona ^{[1
]}

机构：

[1] Univ Tubingen, Dept Pharmaceut & Med Chem, Inst Pharm, D-72076 Tubingen, Germany

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2008年 / 51卷 / 08期

关键词：

D O I：

10.1021/jm701343f

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

SAR of N-alkylated isoxazolones as p38 MAP kinase inhibitors was realized. The data herein show the possibility of transferring the SAR study and evaluation from N-1-substituted imidazole to isoxazolones. Optimization of substituent was realized.

引用

页码：2580 / 2584

页数：5

共 50 条

[21] Simultaneous activation of p38[alpha] and p38[beta] MAP kinases induced intracellular vacuole formation
Goo, YL
Yang, BH
Cao, DJ
Colman, RW
FASEB JOURNAL, 2004, 18 (04): : A636 - A637
[22] THE P38α AND P38δ MAP KINASES MAY BE GENE THERAPY TARGETS IN THE FUTURE TREATMENT OF SEVERE BURNS
Wang, Shuyun
Huang, Qiaobing
Guo, Xiaohua
Brunk, Ulf T.
Han, Jiahuai
Zhao, Keseng
Zhao, Ming
SHOCK, 2010, 34 (02): : 176 - 182
[23] Regulation of skeletal muscle gene expression by p38 MAP kinases
Lluís, F
Perdiguero, E
Nebreda, AR
Muñoz-Cánoves, P
TRENDS IN CELL BIOLOGY, 2006, 16 (01) : 36 - 44
[24] The differential role of ERK and p38 MAP kinases in eosinophil functions
Adachi, T
Choudhury, BK
Stafford, S
Sur, S
Alam, R
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S91 - S91
[25] Potential adverse effects associated with inhibition of p38α/β MAP kinases
Dambach, DM
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (10) : 929 - 939
[26] Identification of p38α MAP kinase inhibitors by pharmacophore based virtual screening
Gangwal, Rahul P.
Das, Nihar R.
Thanki, Kaushik
Damre, Mangesh V.
Dhoke, Gaurao V.
Sharma, Shyam S.
Jain, Sanyog
Sangamwar, Abhay T.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2014, 49 : 18 - 24
[27] Synthesis and SAR of p38α MAP kinase inhibitors based on heterobicyclic scaffolds
Dhar, T. G. Murali
Wrobleski, Stephen T.
Lin, Shuqun
Furch, Joseph A.
Nirschl, David S.
Fan, Yi
Todderud, Gordon
Pitt, Sidney
Doweyko, Arthur M.
Sack, John S.
Mathur, Arvind
McKinnon, Murray
Barrish, Joel C.
Dodd, John H.
Schieven, Gary L.
Leftheris, Katerina
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (18) : 5019 - 5024
[28] MAP kinase p38 inhibitors:: Clinical results and an intimate look at their interactions with p38α protein
Lee, MR
Dominguez, C
CURRENT MEDICINAL CHEMISTRY, 2005, 12 (25) : 2979 - 2994
[29] P38 α map kinase inhibitors:: From discovery to the clinic
Dugar, S
Mavunkel, B
Chakravarty, S
Perumattam, J
Luedtke, G
Lu, Q
Chen, Z
Xu, YJ
Protter, A
Schreiner, G
Almirez, R
Scott, B
Laney, M
Henson, M
Lewicki, J
Moore, A
Lee, S
Brahn, E
Liu, D
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U162 - U162
[30] p38 MAP kinase inhibitors: Progress, pitfalls and possibilities
Adams, JL
Gallagher, TF
Boehm, JC
Kassis, S
Gorycki, PD
Gum, RJ
Webb, EF
Sorenson, ME
Smietana, JM
Garigipati, RS
Hall, RF
Ayrton, A
Badger, A
Griswold, DE
Young, PR
Lee, JC
MEDICINAL CHEMISTRY INTO THE MILLENNIUM, 2001, (264): : 163 - 173

← 1 2 3 4 5 →